Fig. 2From: Combination of NF-kB targeted siRNA and methotrexate in a hybrid nanocarrier towards the effective treatment in rheumatoid arthritisa In vitro drug release of methotrexate from siRML and F-siRML. The drug release study was performed in PBS (pH 7.4) and the amount of drug release was estimated by HPLC analysis; b in vitro drug release of siRNA from both the formationsBack to article page